Risk of stroke following SARS-CoV-2 infection in a nationwide self-controlled case series study in qatar

Sci Rep. 2026 Apr 20. doi: 10.1038/s41598-026-47216-z. Online ahead of print.

Hiam Chemaitelly^{1

2}, Naveed Akhtar³, Salman Al Jerdi^{3

4}, Saadat Kamran³, Sujatha Joseph³, Deborah Morgan³, Ryan Uy³, Fatma Ben Abid^{4

5

6}, Abdullatif Al-Khal⁵, Abdul-Badi Abou-Samra⁷, Adeel A Butt^{8

7

9}, Laith J Abu-Raddad^{10

8

11

12}

¹ Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar. hsc2001@qatar-med.cornell.edu.
² Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, USA. hsc2001@qatar-med.cornell.edu.
³ Neurosciences Institute, Hamad Medical Corporation, Doha, Qatar.
⁴ Department of Medical Education, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
⁵ Infectious Disease Division, Hamad Medical Corporation, Doha, Qatar.
⁶ College of Medicine, QU Health, Qatar University, Doha, Qatar.
⁷ Corporate Quality and Patient Safety Department, Hamad Medical Corporation, Doha, Qatar.
⁸ Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, USA.
⁹ Department of Medicine, Weill Cornell Medicine, Cornell University, New York, USA.
¹⁰ Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
¹¹ Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
¹² College of Health and Life Sciences, Hamad bin Khalifa University, Doha, Qatar.

No abstract available

Keywords: Adverse event; COVID-19; Hemorrhagic; Ischemic; Risk; Thrombosis.

Grants and funding